dihydroergotoxine and Hearing-Loss--Sensorineural

dihydroergotoxine has been researched along with Hearing-Loss--Sensorineural* in 2 studies

Other Studies

2 other study(ies) available for dihydroergotoxine and Hearing-Loss--Sensorineural

Article	Year
[Experience in the administration of vasobral in sensorineural vascular hypoasusis]. Vestnik otorinolaringologii, 2001, Issue:2 24 patients with neurosensory hypoacusis of vascular genesis related to chronic cerebral vascular deficiency in the vertebrobasillar bed combined with cervical osteochondrosis were given basobral. The drug produced positive changes in neurological symptoms, lowered hearing thresholds in the range of high frequencies, improved cerebral hemodynamics and hearing afferentation at the stem level of the acoustic analyzer. Topics: Administration, Oral; Adult; Caffeine; Dihydroergotoxine; Drug Administration Schedule; Drug Combinations; Hearing Loss, Sensorineural; Humans; Neuroprotective Agents; Osteochondritis; Retrospective Studies; Vertebrobasilar Insufficiency	2001
[Hydergine in pathology of the inner ear]. Anales otorrinolaringologicos ibero-americanos, 1990, Volume: 17, Issue:1 There have been treated a total of 20 patients with troubles on the cochlear compartment and/or vestibular level which have been clinically expressed by a perceptive hypoacusia, tinnitus and rotatory vertigo. The final evaluation is referred to 17 patients, since three patients do not appear for control. All patients were treated only with Hydergine, on doses of 30 drops thrice daily, which is the equivalent to 4.5 mg/day of active substance. This treatment remained unaltered till the end of the last control. Controls have been effected after 30, 60 and 90 days of starting the treatment. In each control there was evaluated the subjective improvement of vertigo, tinnitus and hypoacusia when effecting to all patients by means of liminar- supraliminar- and automaticaudiometry, impedancimetry, T one-decay-test and electrooculonistagmography. The most meliorated symptomatology was vertigo, with a global improvement of 93.7 per cent on the treated patients. Tinnitus improve by 57.1 per cent and hypoacusia by 20 per cent. There is a total correspondence between the subjective data furnished by the patients and the objective tests carried out in the successive controls. Topics: Adult; Aged; Audiometry; Dihydroergotoxine; Drug Evaluation; Electronystagmography; Electrooculography; Female; Hearing Loss, Sensorineural; Humans; Male; Middle Aged; Tinnitus; Vertigo	1990

Article

Year

[Experience in the administration of vasobral in sensorineural vascular hypoasusis].

Vestnik otorinolaringologii, 2001, Issue:2

24 patients with neurosensory hypoacusis of vascular genesis related to chronic cerebral vascular deficiency in the vertebrobasillar bed combined with cervical osteochondrosis were given basobral. The drug produced positive changes in neurological symptoms, lowered hearing thresholds in the range of high frequencies, improved cerebral hemodynamics and hearing afferentation at the stem level of the acoustic analyzer.

Topics: Administration, Oral; Adult; Caffeine; Dihydroergotoxine; Drug Administration Schedule; Drug Combinations; Hearing Loss, Sensorineural; Humans; Neuroprotective Agents; Osteochondritis; Retrospective Studies; Vertebrobasilar Insufficiency

2001

[Hydergine in pathology of the inner ear].

Anales otorrinolaringologicos ibero-americanos, 1990, Volume: 17, Issue:1

There have been treated a total of 20 patients with troubles on the cochlear compartment and/or vestibular level which have been clinically expressed by a perceptive hypoacusia, tinnitus and rotatory vertigo. The final evaluation is referred to 17 patients, since three patients do not appear for control. All patients were treated only with Hydergine, on doses of 30 drops thrice daily, which is the equivalent to 4.5 mg/day of active substance. This treatment remained unaltered till the end of the last control. Controls have been effected after 30, 60 and 90 days of starting the treatment. In each control there was evaluated the subjective improvement of vertigo, tinnitus and hypoacusia when effecting to all patients by means of liminar- supraliminar- and automaticaudiometry, impedancimetry, T one-decay-test and electrooculonistagmography. The most meliorated symptomatology was vertigo, with a global improvement of 93.7 per cent on the treated patients. Tinnitus improve by 57.1 per cent and hypoacusia by 20 per cent. There is a total correspondence between the subjective data furnished by the patients and the objective tests carried out in the successive controls.

Topics: Adult; Aged; Audiometry; Dihydroergotoxine; Drug Evaluation; Electronystagmography; Electrooculography; Female; Hearing Loss, Sensorineural; Humans; Male; Middle Aged; Tinnitus; Vertigo

1990